Chase Beisel, at JMU and department head at HIRI, received an ERC Proof of Concept Grant. (Image: HIRI / Luisa Macharowsky)
Chase Beisel, at JMU and department head at HIRI, received an ERC Proof of Concept Grant. (Image: HIRI / Luisa Macharowsky) Chase Beisel, CRISPR expert at the Helmholtz Institute for RNA-based Infection Research, has been awarded an ERC Proof of Concept Grant. The aim of his research is to simplify the production of cell-based therapies. CRISPR technologies have revolutionized genome editing: they can modify virtually any DNA-at any genomic site in any organism. However, in many cases, the procedure is inefficient, and the quantity of modified cells is very low. To identify and isolate cells with the desired edits, extensive screening can be required. Relief could come from a mechanism recently discovered by a research team led by the Helmholtz Institute Würzburg.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
